Analysis of the EF24-modulated signaling pathways for thedevelopment of novel cancer combination therapies
1 of 10
Escalation with Overdose Control using a Toxicity Score for Personalized Maximum Tolerated Dose in Phase I Clinical Trials
2 of 10
Survival outcomes in patients with early stage, resectable
pancreatic cancer - a comparison of gemcitabine and 5-fluorouracil
based treatment regimens.
3 of 10
Oropharyngeal Squamous Cell Carcinoma and Human Papillomavirus in African American Populations
4 of 10
Chemo-radiation With or Without Surgery for Resectable Esophageal Cancer: An Analysis of Survival among 11,122 Patients in the National Cancer Data Base (NCDB)
5 of 10
Rifaximin for Preventing Acute Graft Versus Host Disease: Impact on
Plasma Markers of Inflammation and T Cell Activation
6 of 10
RESIDENCE PROXIMITY TO BENZENE RELEASE SITES IN GEORGIA AND NON-
HODGKIN'S LYMPHOMA
7 of 10
Outcomes of Tumor-Directed Surgery in Cancers of Head of Pancreas,
Ampulla and Extrahepatic Bile Ducts: Influence of Patient
Demographics, Disease Characteristics and Geographic Factors
8 of 10
Effects of Stable Insulin-like Growth Factor 1 Receptor Knockdown
on Triple-Negative Breast Cancer Cells
9 of 10
Pigment Epithelium-Derived Factor (PEDF) Inhibits Progression of
Liver Metastasis in a Mouse Model of Uveal Melanoma